pbluescript sk1 (pbssk (Agilent technologies)
Agilent technologies is a verified supplier 
Agilent technologies manufactures this product 
90
Structured Review
Agilent technologies
pbluescript sk1 (pbssk
Pbluescript Sk1 (Pbssk, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pbluescript+sk1+(pbssk/pm25395220-50-15-19
Average 90 stars, based on 1 article reviews
Pbluescript Sk1 (Pbssk, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pbluescript+sk1+(pbssk/pm25395220-50-15-19
Average 90 stars, based on 1 article reviews
pbluescript sk1 (pbssk - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Expressing:Article Title: Uncovering methods for the prevention of protein aggregation and improvement of product quality in a transient expression system. Article Snippet: Expression vector pTT5 is licensed from the National Research Council of Canada (NRCC).4,7 pTT5 and Article Title: Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer Article Snippet: RARb promoter constructs were derived from human RARb2 promoter sequences contained within plasmid pD1 (19). pD1 was digested with BglII-BamHI, and the fragment spanning2747 to1156 of the RARb2 promoter was ligated into the BamHI site of Plasmid Preparation:Article Title: Uncovering methods for the prevention of protein aggregation and improvement of product quality in a transient expression system. Article Snippet: Expression vector pTT5 is licensed from the National Research Council of Canada (NRCC).4,7 pTT5 and Article Title: Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer Article Snippet: RARb promoter constructs were derived from human RARb2 promoter sequences contained within plasmid pD1 (19). pD1 was digested with BglII-BamHI, and the fragment spanning2747 to1156 of the RARb2 promoter was ligated into the BamHI site of Construct:Article Title: Uncovering methods for the prevention of protein aggregation and improvement of product quality in a transient expression system. Article Snippet: Expression vector pTT5 is licensed from the National Research Council of Canada (NRCC).4,7 pTT5 and Article Title: Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer Article Snippet: RARb promoter constructs were derived from human RARb2 promoter sequences contained within plasmid pD1 (19). pD1 was digested with BglII-BamHI, and the fragment spanning2747 to1156 of the RARb2 promoter was ligated into the BamHI site of Derivative Assay:Article Title: Uncovering methods for the prevention of protein aggregation and improvement of product quality in a transient expression system. Article Snippet: Expression vector pTT5 is licensed from the National Research Council of Canada (NRCC).4,7 pTT5 and Article Title: Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer Article Snippet: RARb promoter constructs were derived from human RARb2 promoter sequences contained within plasmid pD1 (19). pD1 was digested with BglII-BamHI, and the fragment spanning2747 to1156 of the RARb2 promoter was ligated into the BamHI site of Ligation:Article Title: Uncovering methods for the prevention of protein aggregation and improvement of product quality in a transient expression system. Article Snippet: Expression vector pTT5 is licensed from the National Research Council of Canada (NRCC).4,7 pTT5 and Article Title: Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer Article Snippet: RARb promoter constructs were derived from human RARb2 promoter sequences contained within plasmid pD1 (19). pD1 was digested with BglII-BamHI, and the fragment spanning2747 to1156 of the RARb2 promoter was ligated into the BamHI site of Luciferase:Article Title: Uncovering methods for the prevention of protein aggregation and improvement of product quality in a transient expression system. Article Snippet: Expression vector pTT5 is licensed from the National Research Council of Canada (NRCC).4,7 pTT5 and Article Title: Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer Article Snippet: RARb promoter constructs were derived from human RARb2 promoter sequences contained within plasmid pD1 (19). pD1 was digested with BglII-BamHI, and the fragment spanning2747 to1156 of the RARb2 promoter was ligated into the BamHI site of Generated:Article Title: Uncovering methods for the prevention of protein aggregation and improvement of product quality in a transient expression system. Article Snippet: Expression vector pTT5 is licensed from the National Research Council of Canada (NRCC).4,7 pTT5 and Article Title: Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer Article Snippet: RARb promoter constructs were derived from human RARb2 promoter sequences contained within plasmid pD1 (19). pD1 was digested with BglII-BamHI, and the fragment spanning2747 to1156 of the RARb2 promoter was ligated into the BamHI site of |